{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:13:41Z","timestamp":1794320021777,"version":"4.9.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institute for Health Research (NIHR) Health Protection Research Unit in Gastrointestinal Infections"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Effective infectious disease diagnostics (IDD) are vital for informing clinical decision-making regarding the treatment and patient management of disease and infections. In England, conventional clinical methods rely upon culture-dependent techniques, and there has been little shift in the acceptance and integration of culture-independent sequencing methods into routine clinical IDD. This study explored stakeholders\u2019 experiences within IDD, including those working in clinical settings and those conducting research at the forefront of microbial genomics. From the participants\u2019 experiences, the study aimed to identify barriers and facilitators driving the development and implementation of metagenome sequencing as a routine diagnostic.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Virtual semi-structured interviews were conducted with purposively selected individuals involved in IDD. The interviews explored the experiences of implementing metagenome sequencing as a diagnostic tool and decisions about which diagnostics are used for identifying bacteria-causing infections. Thematic analysis was used to analyse the data, and an Interpretive Phenomenological approach was used throughout.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Ten individuals were interviewed between July 2021 and October 2021, including clinical scientists, consultants, and professors in academia. Their experience ranged from limited knowledge of metagenome sequencing to an expert understanding of the phenomenon. The thoughts and perspectives of participants of the study could be grouped into five themes: Availability of diagnostics for infectious diseases; Clinical laboratory infrastructure; Ethical Data Sharing: Enhancing metagenomics through Open Access; Case study in action: COVID-19; and The importance of communication to improve developments of new diagnostics. Participants recognised the need for new diagnostics to be implemented to overcome the limitations of current diagnostic approaches but highlighted the barriers to integrating new diagnostics into clinical settings, such as the impact on clinical decision-making, accreditation, and cost. Further, participants felt that lessons could be learnt from using metagenomics in COVID-19 and how other diagnostic platforms have been integrated into clinical settings over the last 20 years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The study provided insights into stakeholders\u2019 perspectives and opinions to address the knowledge gap in current literature and identified barriers and facilitators which drive the implementation of metagenome sequencing as a routine IDD in clinical settings. Knowledge of new and upcoming genomic diagnostic testing is not equally distributed throughout the UK, impacting the understanding and drive to integrate metagenome sequencing into routine clinical diagnostics. Improvements in access to new diagnostics could improve patient treatment and management and positively impact population health.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12879-025-10820-x","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T16:44:59Z","timestamp":1743439499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Academic and clinical perspectives of metagenome sequencing as a diagnostic tool for infectious disease: an interpretive phenomenological study"],"prefix":"10.1186","volume":"25","author":[{"given":"Hannah","family":"Trivett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair C.","family":"Darby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oyinlola","family":"Oyebode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"issue":"3","key":"10820_CR1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3748\/wjg.v21.i3.803","volume":"21","author":"WL Wang","year":"2015","unstructured":"Wang WL, Xu SY, Ren ZG, Tao L, Jiang JW, Zheng SS. Application of metagenomics in the human gut Microbiome. World J Gastroenterol WJG. 2015;21(3):803\u201314.","journal-title":"World J Gastroenterol WJG"},{"issue":"10","key":"10820_CR2","doi-asserted-by":"crossref","first-page":"e02446","DOI":"10.1128\/jcm.02446-21","volume":"60","author":"JE Schmitz","year":"2022","unstructured":"Schmitz JE, Stratton CW, Persing DH, Tang YW. Forty years of molecular diagnostics for infectious diseases. J Clin Microbiol. 2022;60(10):e02446\u201321.","journal-title":"J Clin Microbiol"},{"key":"10820_CR3","doi-asserted-by":"crossref","first-page":"105377","DOI":"10.1016\/j.actatropica.2020.105377","volume":"205","author":"A Hahn","year":"2020","unstructured":"Hahn A, Podbielski A, Meyer T, Zautner AE, Loderst\u00e4dt U, Schwarz NG, et al. On detection thresholds\u2013a review on diagnostic approaches in the infectious disease laboratory and the interpretation of their results. Acta Trop. 2020;205:105377.","journal-title":"Acta Trop"},{"issue":"5","key":"10820_CR4","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s13365-023-01157-9","volume":"29","author":"K Perlejewski","year":"2023","unstructured":"Perlejewski K, Radkowski M, Rydzanicz M, Dzieci\u0105tkowski T, Silling S, Wieczorek M, et al. Metagenomic search of viral coinfections in herpes simplex encephalitis patients. J Neurovirol. 2023;29(5):588\u201397.","journal-title":"J Neurovirol"},{"issue":"9","key":"10820_CR5","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/cid\/ciy303","volume":"67","author":"MJ Thoendel","year":"2018","unstructured":"Thoendel MJ, Jeraldo PR, Greenwood-Quaintance KE, Yao JZ, Chia N, Hanssen AD, et al. Identification of prosthetic joint infection pathogens using a shotgun metagenomics approach. Clin Infect Dis Off Publ Infect Dis Soc Am. 2018;67(9):1333\u20138.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"1","key":"10820_CR6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12931-024-02991-z","volume":"25","author":"J Zhao","year":"2024","unstructured":"Zhao J, Sun Y, Tang J, Guo K, Wang K, Zhuge J, et al. The clinical application of metagenomic next-generation sequencing in immunocompromised patients with severe respiratory infections in the ICU. Respir Res. 2024;25(1):360.","journal-title":"Respir Res"},{"issue":"1","key":"10820_CR7","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12920-024-02044-w","volume":"17","author":"C Halford","year":"2024","unstructured":"Halford C, Le Viet T, Edge K, Russell P, Moore N, Trim F, et al. Development of a clinical metagenomics workflow for the diagnosis of wound infections. BMC Med Genomics. 2024;17(1):276.","journal-title":"BMC Med Genomics"},{"issue":"5","key":"10820_CR8","doi-asserted-by":"crossref","first-page":"bbaa403","DOI":"10.1093\/bib\/bbaa403","volume":"22","author":"D Sheka","year":"2021","unstructured":"Sheka D, Alabi N, Gordon PMK. Oxford nanopore sequencing in clinical microbiology and infection diagnostics. Brief Bioinform. 2021;22(5):bbaa403.","journal-title":"Brief Bioinform"},{"key":"10820_CR9","doi-asserted-by":"publisher","unstructured":"Behera S, Catreux S, Rossi M, Truong S, Huang Z, Ruehle M et al. Comprehensive genome analysis and variant detection at scale using DRAGEN. Nat Biotechnol. 2024; Available from: https:\/\/doi.org\/10.1038\/s41587-024-02382-1","DOI":"10.1038\/s41587-024-02382-1"},{"issue":"1","key":"10820_CR10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12859-021-04089-5","volume":"22","author":"J Fan","year":"2021","unstructured":"Fan J, Huang S, Chorlton SD. BugSeq: a highly accurate cloud platform for long-read metagenomic analyses. BMC Bioinformatics. 2021;22(1):160.","journal-title":"BMC Bioinformatics"},{"key":"10820_CR11","doi-asserted-by":"publisher","unstructured":"Batool M, Galloway-Pe\u00f1a J. Clinical metagenomics\u2014challenges and future prospects. Front Microbiol. 2023;14. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fmicb.2023.1186424","DOI":"10.3389\/fmicb.2023.1186424"},{"issue":"7","key":"10820_CR12","doi-asserted-by":"crossref","first-page":"001066","DOI":"10.1099\/mgen.0.001066","volume":"9","author":"N Ring","year":"2023","unstructured":"Ring N, Low AS, Wee B, Paterson GK, Nuttall T, Gally D, et al. Rapid metagenomic sequencing for diagnosis and antimicrobial sensitivity prediction of canine bacterial infections. Microb Genomics. 2023;9(7):001066.","journal-title":"Microb Genomics"},{"issue":"1","key":"10820_CR13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13054-023-04365-1","volume":"27","author":"LPA Neyton","year":"2023","unstructured":"Neyton LPA, Langelier CR, Calfee CS. Metagenomic sequencing in the ICU for precision diagnosis of critical infectious illnesses. Crit Care. 2023;27(1):90.","journal-title":"Crit Care"},{"issue":"2","key":"10820_CR14","doi-asserted-by":"crossref","first-page":"e01267","DOI":"10.1128\/jcm.01267-22","volume":"61","author":"DC Gaston","year":"2023","unstructured":"Gaston DC. Clinical metagenomics for infectious diseases: progress toward operational value. J Clin Microbiol. 2023;61(2):e01267\u201322.","journal-title":"J Clin Microbiol"},{"key":"10820_CR15","doi-asserted-by":"publisher","unstructured":"Goldberg B, Sichtig H, Geyer C, Ledeboer N, Weinstock GM. Making the leap from research laboratory to clinic: challenges and opportunities for Next-Generation sequencing in infectious disease diagnostics. mBio. 2015;6(6). https:\/\/doi.org\/10.1128\/mbio.01888-15","DOI":"10.1128\/mbio.01888-15"},{"key":"10820_CR16","doi-asserted-by":"publisher","unstructured":"Govender KN, Street TL, Sanderson ND, Eyre DW. Metagenomic sequencing as a Pathogen-Agnostic clinical diagnostic tool for infectious diseases: a systematic review and Meta-analysis of diagnostic test accuracy studies. J Clin Microbiol. 2021;59(9). https:\/\/doi.org\/10.1128\/jcm.02916-20","DOI":"10.1128\/jcm.02916-20"},{"issue":"1","key":"10820_CR17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13756-021-00961-4","volume":"10","author":"AM Pandolfo","year":"2021","unstructured":"Pandolfo AM, Horne R, Jani Y, Reader TW, Bidad N, Brealey D, et al. Intensivists\u2019 beliefs about rapid multiplex molecular diagnostic testing and its potential role in improving prescribing decisions and antimicrobial stewardship: a qualitative study. Antimicrob Resist Infect Control. 2021;10(1):95.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"4","key":"10820_CR18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/17579139221083814","volume":"142","author":"T Stickley","year":"2022","unstructured":"Stickley T, O\u2019Caithain A, Homer C. The value of qualitative methods to public health research, policy and practice. Perspect Public Health. 2022;142(4):237\u201340.","journal-title":"Perspect Public Health"},{"issue":"10","key":"10820_CR19","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1177\/1049732307307031","volume":"17","author":"H Starks","year":"2007","unstructured":"Starks H, Brown Trinidad S. Choose your method: A comparison of phenomenology, discourse analysis, and grounded theory. Qual Health Res. 2007;17(10):1372\u201380.","journal-title":"Qual Health Res"},{"issue":"1","key":"10820_CR20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/ebnurs-2018-103017","volume":"22","author":"G Peat","year":"2019","unstructured":"Peat G, Rodriguez A, Smith J. Interpretive phenomenological analysis applied to healthcare research. Evid Based Nurs. 2019;22(1):7\u20139.","journal-title":"Evid Based Nurs"},{"issue":"6","key":"10820_CR21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"key":"10820_CR22","doi-asserted-by":"crossref","unstructured":"Tindall LJA, Smith P, Flower, Larkin M. (2009), Interpretative Phenomenological Analysis: Theory, Method and Research. Qual Res Psychol. 2009;6(4):346\u20137.","DOI":"10.1080\/14780880903340091"},{"key":"10820_CR23","doi-asserted-by":"crossref","first-page":"160940692312057","DOI":"10.1177\/16094069231205789","volume":"22","author":"M Naeem","year":"2023","unstructured":"Naeem M, Ozuem W, Howell K, Ranfagni S. A Step-by-Step process of thematic analysis to develop a conceptual model in qualitative research. Int J Qual Methods. 2023;22:16094069231205789.","journal-title":"Int J Qual Methods"},{"issue":"3","key":"10820_CR24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/nop2.275","volume":"6","author":"AJ Sundler","year":"2019","unstructured":"Sundler AJ, Lindberg E, Nilsson C, Palm\u00e9r L. Qualitative thematic analysis based on descriptive phenomenology. Nurs Open. 2019;6(3):733\u20139.","journal-title":"Nurs Open"},{"key":"10820_CR25","unstructured":"Anderson M, Pinchforth E, Edwards N, Alderwick H, McGuire A, Mossialos E. United Kingdom: health system review 2022. 2022. Available from: https:\/\/eurohealthobservatory.who.int\/publications\/i\/united-kingdom-health-system-review-2022"},{"key":"10820_CR26","unstructured":"Genome GOVUK. UK: shared commitments for UK-wide implementation 2022 to 2025. 2020. Available from: https:\/\/www.gov.uk\/government\/publications\/genome-uk-shared-commitments-for-uk-wide-implementation-2022-to-2025\/genome-uk-shared-commitments-for-uk-wide-implementation-2022-to-2025"},{"key":"10820_CR27","unstructured":"The Scottish Government. Genomics in Scotland: Building our Future. 2024. Available from: https:\/\/www.gov.scot\/binaries\/content\/documents\/govscot\/publications\/strategy-plan\/2024\/04\/scotlands-genomic-medicine-strategy-2024-2029\/documents\/genomics-scotland-building-future\/genomics-scotland-building-future\/govscot%3Adocument\/genomics-scotland-building-future.pdf"},{"key":"10820_CR28","unstructured":"Government W, Cymru L. Genomics Delivery Plan for Wales. 2022; Available from: https:\/\/www.gov.wales\/sites\/default\/files\/publications\/2022-11\/genomics-delivery-plan-for-wales_0.pdf"},{"key":"10820_CR29","unstructured":"UKHSA. GOV.UK. 2024. UKHSA Pathogen Genomics Strategy. Available from: https:\/\/www.gov.uk\/government\/publications\/ukhsa-pathogen-genomics-strategy"},{"issue":"3","key":"10820_CR30","first-page":"111","volume":"93","author":"A Karthikeyan","year":"2024","unstructured":"Karthikeyan A, McKee S, McKay GJ. Integration of genomic medicine to mainstream patient care within the UK National health service. Ulster Med J. 2024;93(3):111\u20138.","journal-title":"Ulster Med J"},{"key":"10820_CR31","unstructured":"Oxford Nanopore Technologies. 2024 [cited 2025 Jan 22]. Oxford Nanopore announces landmark UK Government partnership to advance genomics-driven healthcare innovation in the UK. Available from: https:\/\/nanoporetech.com\/news\/oxford-nanopore-announces-landmark-uk-government-partnership-to-advance-genomics-driven-healthcare-innovation-in-the-uk"},{"key":"10820_CR32","unstructured":"Johnston I, Peel M. UK health agencies join with Oxford Nanopore to speed up pathogen screening. Financial Times. 2024 Nov 5 [cited 2025 Jan 22]; Available from: https:\/\/www.ft.com\/content\/a3b33b3e-9216-481a-9a31-71dcb63b7e1a"},{"key":"10820_CR33","doi-asserted-by":"publisher","unstructured":"Miller S, Chiu C, Rodino KG, Miller MB. Point-Counterpoint: should we be performing metagenomic Next-Generation sequencing for infectious disease diagnosis in the clinical laboratory?? J Clin Microbiol. 2020;58(3). https:\/\/doi.org\/10.1128\/jcm.01739-19","DOI":"10.1128\/jcm.01739-19"},{"issue":"2","key":"10820_CR34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/QCO.0000000000000909","volume":"36","author":"JD Edgeworth","year":"2023","unstructured":"Edgeworth JD. Respiratory metagenomics: route to routine service. Curr Opin Infect Dis. 2023;36(2):115\u201323.","journal-title":"Curr Opin Infect Dis"},{"issue":"10","key":"10820_CR35","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/crj.13538","volume":"16","author":"Y Chen","year":"2022","unstructured":"Chen Y, Fan L, Chai Y, Xu J. Advantages and challenges of metagenomic sequencing for the diagnosis of pulmonary infectious diseases. Clin Respir J. 2022;16(10):646\u201356.","journal-title":"Clin Respir J"},{"issue":"9","key":"10820_CR36","first-page":"2624","volume":"109","author":"R Zhu","year":"2023","unstructured":"Zhu R, Hong X, Zhang D, Xiao Y, Xu Q, Wu B, et al. Application of metagenomic sequencing of drainage fluid in rapid and accurate diagnosis of postoperative intra-abdominal infection: a diagnostic study. Int J Surg Lond Engl. 2023;109(9):2624\u201330.","journal-title":"Int J Surg Lond Engl"},{"issue":"1","key":"10820_CR37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13073-015-0220-9","volume":"7","author":"AL Greninger","year":"2015","unstructured":"Greninger AL, Naccache SN, Federman S, Yu G, Mbala P, Bres V, et al. Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis. Genome Med. 2015;7(1):99.","journal-title":"Genome Med"},{"key":"10820_CR38","doi-asserted-by":"publisher","unstructured":"Von Fricken ME, Melendrez MC, Linton YM, Takhampunya R, Editorial. Metagenomics for epidemiological surveillance in One Health. Front Microbiol. 2023 Mar 31 [cited 2024 Sep 17];14. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fmicb.2023.1191946\/full","DOI":"10.3389\/fmicb.2023.1191946\/full"},{"issue":"3","key":"10820_CR39","doi-asserted-by":"crossref","first-page":"00113","DOI":"10.1183\/23120541.00113-2022","volume":"8","author":"Z Stojanovic","year":"2022","unstructured":"Stojanovic Z, Gon\u00e7alves-Carvalho F, Mar\u00edn A, Abad Capa J, Dom\u00ednguez J, Latorre I, et al. Advances in diagnostic tools for respiratory tract infections: from tuberculosis to COVID-19 - changing paradigms? ERJ Open Res. 2022;8(3):00113\u20132022.","journal-title":"ERJ Open Res"},{"issue":"5","key":"10820_CR40","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3390\/microorganisms11051259","volume":"11","author":"E Kamau","year":"2023","unstructured":"Kamau E, Yang S. Metagenomic sequencing of positive blood culture fluid for accurate bacterial and fungal species identification: A pilot study. Microorganisms. 2023;11(5):1259.","journal-title":"Microorganisms"},{"issue":"9","key":"10820_CR41","doi-asserted-by":"crossref","first-page":"e00621","DOI":"10.1128\/jcm.00621-22","volume":"60","author":"L Flurin","year":"2022","unstructured":"Flurin L, Wolf MJ, Fisher CR, Cano Cevallos EJ, Vaillant JJ, Pritt BS, et al. Pathogen detection in infective endocarditis using targeted metagenomics on whole blood and plasma: a prospective pilot study. J Clin Microbiol. 2022;60(9):e00621\u201322.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10820_CR42","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/JCM.01965-15","volume":"54","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Wylie KM, El Feghaly RE, Mihindukulasuriya KA, Elward A, Haslam DB, et al. Metagenomic approach for identification of the pathogens associated with diarrhea in stool specimens. J Clin Microbiol. 2016;54(2):368\u201375.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10820_CR43","first-page":"e62","volume":"1","author":"TM Elliott","year":"2021","unstructured":"Elliott TM, Harris PN, Roberts LW, Doidge M, Hurst T, Hajkowicz K, et al. Cost-effectiveness analysis of whole-genome sequencing during an outbreak of carbapenem-resistant acinetobacter baumannii. Antimicrob Steward Healthc Epidemiol ASHE. 2021;1(1):e62.","journal-title":"Antimicrob Steward Healthc Epidemiol ASHE"},{"issue":"1","key":"10820_CR44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12910-022-00853-1","volume":"23","author":"G Samuel","year":"2022","unstructured":"Samuel G, Ballard LM, Carley H, Lucassen AM. Ethical preparedness in health research and care: the role of behavioural approaches. BMC Med Ethics. 2022;23(1):115.","journal-title":"BMC Med Ethics"},{"key":"10820_CR45","unstructured":"Nuffield Council on Bioethics. Ethics in genomics healthcare and research: building connections and sharing best practice. 2023. Available from: https:\/\/www.nuffieldbioethics.org\/wp-content\/uploads\/FINAL-version-Genomics-workshop-summary-and-analysis.pdf"},{"key":"10820_CR46","unstructured":"NHS England Digital. [cited 2025 Jan 20]. NHS England Secure Data Environment. Available from: https:\/\/digital.nhs.uk\/services\/secure-data-environment-service"},{"key":"10820_CR47","unstructured":"Governemnt Digital Service. Data Ethics Framework. 2020; Available from: https:\/\/assets.publishing.service.gov.uk\/media\/5f74a4958fa8f5188dad0e99\/Data_Ethics_Framework_2020.pdf"},{"key":"10820_CR48","unstructured":"Data Protection Act. 2018. Available from: https:\/\/www.legislation.gov.uk\/ukpga\/2018\/12\/pdfs\/ukpga_20180012_en.pdf"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10820-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10820-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10820-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T16:46:20Z","timestamp":1743439580000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10820-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10820"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10820-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"assertion":[{"value":"3 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study gained ethical approval from the Institute of Life Course and Medical Sciences Research Ethics Committee at the University of Liverpool (Ethical review reference 9855). All methods were carried out following relevant guidelines. All participants were provided with an information sheet. Written informed consent was obtained from all participants before participating in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"448"}}